First Tracks Biotherapeutics Inc (TRAX) Price Prediction & ForecastTRAXFirst Tracks Biotherapeutics Inc

Alphio's TRAX stock price prediction model matches the current First Tracks Biotherapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $41.12 (-0.12%). The 1-week path is $42.01 (+2.03%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

First Tracks Biotherapeutics (TRAX) appears to be a good buy right now, trading at $41.86 with a significant upside potential. Analysts have set price targets ranging from $57 to $95, indicating potential gains of 36% to 127% from the current price. The company has shown strong momentum with an 85.96% year-to-date increase, despite recent volatility. However, the main risk is its negative earnings per share of -0.95 reported in Q2 2026, which reflects ongoing financial challenges.

First Tracks Biotherapeutics Inc (TRAX) last closed at $41.17, losing -1.60%. These facts feed the 1-day and 1-week TRAX price prediction above.